I’m still absorbing the details of the price hike from $13.50 to $750 per tablet of the anti-parasite drug Daraprim after being acquired by Turing Pharmaceuticals, a company run by the human parasite, former hedge-fund manager Martin Shkreli.
I take this personally. Among other things Daraprim is used to treat toxoplasmosis, which I could get, says the Internet, by being too familiar with a cat. I take everything I read on the Internet seriously, especially if it concerns cats, because the Internet is all up in that. ...